Bayer strikes patent deal with ERS Genomics

GenomeWeb, 17 May 2016,

Bayer has licensed the CRISPR/Cas9 patents held by ERS Genomics which will expand upon their preexisting collaboration with CRISPR Therapeutics.  ERS Genomics holds the rights to Emmanuelle Charpentier’s CRISPR patents.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply